AstraZeneca, Amneal Settle Generic Diabetes Drug Fight
Drug companies AstraZeneca and Amneal have settled a patent infringement lawsuit over Amneal's application to sell a generic version of AstraZeneca diabetes drug Byetta, according to a Monday filing in Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article